[go: up one dir, main page]

HRP20000261B1 - 1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3h), 4' -piperidine) hydrohalogenides - Google Patents

1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3h), 4' -piperidine) hydrohalogenides

Info

Publication number
HRP20000261B1
HRP20000261B1 HR20000261A HRP20000261A HRP20000261B1 HR P20000261 B1 HRP20000261 B1 HR P20000261B1 HR 20000261 A HR20000261 A HR 20000261A HR P20000261 A HRP20000261 A HR P20000261A HR P20000261 B1 HRP20000261 B1 HR P20000261B1
Authority
HR
Croatia
Prior art keywords
isobenzofuran
spiro
fluorophenyl
piperidine
butyl
Prior art date
Application number
HR20000261A
Other languages
English (en)
Croatian (hr)
Inventor
Niels Mork
Lopez De Diego Heidi
Nielsen Ole
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of HRP20000261A2 publication Critical patent/HRP20000261A2/hr
Publication of HRP20000261B1 publication Critical patent/HRP20000261B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20000261A 1997-11-07 1998-11-06 1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3h), 4' -piperidine) hydrohalogenides HRP20000261B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK126797 1997-11-07
PCT/DK1998/000480 WO1999024436A1 (en) 1997-11-07 1998-11-06 1'-[4-[1- (4-fluorophenyl)- 1h-indole-3-yl] -1-butyl]-spiro [isobenzofuran- 1(3h),4'- piperidine] hydrohalogenides

Publications (2)

Publication Number Publication Date
HRP20000261A2 HRP20000261A2 (en) 2001-04-30
HRP20000261B1 true HRP20000261B1 (en) 2009-04-30

Family

ID=8102935

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20000261A HRP20000261B1 (en) 1997-11-07 1998-11-06 1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3h), 4' -piperidine) hydrohalogenides

Country Status (38)

Country Link
US (2) US6844352B2 (is)
EP (1) EP1044202B1 (is)
JP (1) JP3605358B2 (is)
KR (1) KR100399274B1 (is)
CN (1) CN1105115C (is)
AR (1) AR023010A1 (is)
AT (1) ATE288918T1 (is)
AU (1) AU749094B2 (is)
BG (1) BG64906B1 (is)
BR (1) BR9813949A (is)
CA (1) CA2308745C (is)
CZ (1) CZ288666B6 (is)
DE (1) DE69828999T2 (is)
DZ (1) DZ2642A1 (is)
EA (1) EA002092B1 (is)
EG (1) EG23791A (is)
ES (1) ES2234162T3 (is)
HR (1) HRP20000261B1 (is)
HU (1) HUP0100991A3 (is)
ID (1) ID25776A (is)
IL (1) IL135723A (is)
IS (1) IS2342B (is)
JO (1) JO2052B1 (is)
MA (1) MA25585A1 (is)
NO (1) NO325920B1 (is)
NZ (1) NZ504065A (is)
PE (1) PE130299A1 (is)
PL (1) PL190538B1 (is)
PT (1) PT1044202E (is)
RS (1) RS49777B (is)
SK (1) SK285245B6 (is)
TN (1) TNSN98201A1 (is)
TR (1) TR200001267T2 (is)
TW (1) TW483894B (is)
UA (1) UA64769C2 (is)
UY (1) UY25236A1 (is)
WO (1) WO1999024436A1 (is)
ZA (1) ZA9810116B (is)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR030453A1 (es) * 2000-08-15 2003-08-20 Lundbeck & Co As H Composicion farmaceutica con contenido de 1' [4-[1-(4-fluorofenil)-1h-indol-3-il]-1-butil] espiro [isobenzofuran-1 (3h), 4'-piperidina]
AU2003263155A1 (en) * 2002-09-20 2004-04-08 H. Lundbeck A/S Method for manufacture of dihydroisobenzofuran derivatives
WO2004110388A2 (en) 2003-06-12 2004-12-23 Agy Therapeutics, Inc. Sigma ligands for neuronal regeneration and functional recovery
WO2007012319A1 (de) * 2005-07-29 2007-02-01 Sigma-Aldrich Production Gmbh Ionisierungsadditive enthaltende lc/ms-blends
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP1991212A1 (en) * 2006-03-08 2008-11-19 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2026813A2 (en) 2006-05-09 2009-02-25 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20080103165A1 (en) * 2006-09-19 2008-05-01 Braincells, Inc. Ppar mediated modulation of neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022554A1 (en) * 1991-06-13 1992-12-23 H. Lundbeck A/S Piperidine derivates having anxiolytic effect

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022554A1 (en) * 1991-06-13 1992-12-23 H. Lundbeck A/S Piperidine derivates having anxiolytic effect

Also Published As

Publication number Publication date
IL135723A0 (en) 2001-05-20
NZ504065A (en) 2002-05-31
IL135723A (en) 2005-11-20
MA25585A1 (fr) 2002-12-31
CZ20001663A3 (cs) 2000-10-11
CN1278823A (zh) 2001-01-03
AU1022699A (en) 1999-05-31
HRP20000261A2 (en) 2001-04-30
CZ288666B6 (cs) 2001-08-15
BG64906B1 (bg) 2006-08-31
JP3605358B2 (ja) 2004-12-22
PT1044202E (pt) 2005-04-29
US20030055074A1 (en) 2003-03-20
NO20002188D0 (no) 2000-04-27
BR9813949A (pt) 2000-09-26
ZA9810116B (en) 1999-05-07
CN1105115C (zh) 2003-04-09
AU749094B2 (en) 2002-06-20
TR200001267T2 (tr) 2000-09-21
PE130299A1 (es) 1999-12-16
KR20010031791A (ko) 2001-04-16
UA64769C2 (uk) 2004-03-15
UY25236A1 (es) 2000-12-29
HK1034075A1 (en) 2001-10-12
RS49777B (sr) 2008-06-05
EP1044202B1 (en) 2005-02-09
ES2234162T3 (es) 2005-06-16
ATE288918T1 (de) 2005-02-15
ID25776A (id) 2000-11-02
HUP0100991A2 (hu) 2001-09-28
US6844352B2 (en) 2005-01-18
YU23500A (sh) 2003-12-31
DZ2642A1 (fr) 2004-12-28
JO2052B1 (en) 1999-05-15
EA002092B1 (ru) 2001-12-24
KR100399274B1 (ko) 2003-09-26
PL190538B1 (pl) 2005-12-30
HUP0100991A3 (en) 2003-03-28
SK285245B6 (sk) 2006-09-07
IS2342B (is) 2008-02-15
AR023010A1 (es) 2002-09-04
EA200000502A1 (ru) 2000-10-30
CA2308745C (en) 2004-01-20
EG23791A (en) 2007-08-13
JP2001522852A (ja) 2001-11-20
NO325920B1 (no) 2008-08-18
IS5460A (is) 2000-04-18
WO1999024436A1 (en) 1999-05-20
US20050171135A1 (en) 2005-08-04
TW483894B (en) 2002-04-21
TNSN98201A1 (fr) 2005-03-15
SK6462000A3 (en) 2000-10-09
BG104485A (en) 2001-01-31
DE69828999D1 (de) 2005-03-17
DE69828999T2 (de) 2005-07-21
CA2308745A1 (en) 1999-05-20
PL340220A1 (en) 2001-01-15
NO20002188L (no) 2000-06-14
EP1044202A1 (en) 2000-10-18

Similar Documents

Publication Publication Date Title
HRP20000261B1 (en) 1'-(4-(1-(4-fluorophenyl)-1h-indole-3-yl)-1-butyl)-spiro (isobenzofuran-1(3h), 4' -piperidine) hydrohalogenides
ATE173255T1 (de) 3-(5-tetrazolyl-benzyl) aminopiperidin-derivate und tachykinin antagonisten
TR200000107T2 (tr) Sübstitüe edilmiş 2-(2,6-dioksopiperidin-3-il) -ftalimidler ve -1-oksoizoindolinler ve TNF alfa seviyelerini düşürmek için yöntem.
DK0776893T3 (da) Azaheterocykliske forbindelser med tachykininreceptorantagonistaktivitet; NK1 og NK2
AU5374294A (en) 4-carboxoamido piperidine derivatives, intermediates and use as neurokinin antagonists
NO974686L (no) Nye substituerte piperazinderivater med tachykininreseptorantagonistisk aktivitet
DK0855999T3 (da) 1-(1,2-disubstituerede piperidinyl)-4-substituerede piperidinderivater som tachykininreceptorantagonister
DE69722143T2 (de) Verschliessvorrichtung und Tintenstrahlgerät unter Verwendung derselben
NO975711L (no) Nye Dolastatinderivater, deres fremstilling og anvendelse
DK347986D0 (da) N-substituerede arylalkyl- og -arylalkylenaminoheterocycliske forbindelser og deres anvendelse som cardiovaskulaere, antihistamin- og antisekretoriske midler
NO931364L (no) Tachykinin reseptorantagonister, isokinoloner og deres fremstilling
IT8920052A0 (it) Dispositivo ausiliario per aprire e chiudere coperchi supportati orientabili, piastre di copertura e similari.
FI961977A0 (fi) N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö
DE69612533D1 (de) Aufzeichnungskopf, Kopfkassette und Aufzeichnungsvorrichtung
DK1044202T3 (da) 1'-[4-[1-(4-Fluorphenyl)-1H-indol-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4'-piperidin]hydrohalogenider
TR200001933T2 (tr) Paroksetin hidroklorid hazırlama prosesi.
DE68913796D1 (de) Schlüssel und Schlüsselhalter.
TR200002891T2 (tr) Panik ataklarının tedavisi
IT1279810B1 (it) Attrezzo per frazionare elementi piastriformi ed uso relativo
SI1044202T1 (en) 1'- 4- 1- (4-fluorophenyl)- 1h-indole-3-yl) -1-butyl)-spiro isobenzofuran- 1(3h),4'- piperidine) hydrohalogenides
ES295227Y (es) Dispositivo automatico de mando para apertura y cierre de la llave incorporada en el regulador de bombonas de gas
KR950016915U (ko) 강판 코블방지를 위한 안내장치
AU2903497A (en) Piperazine, piperidine and tetrahydropyridine derivatives as 5-ht receptor agonists
IT1293097B1 (it) Comando vocale per serrature e porte
IT8846825A0 (it) Dispositivo anti-svergolamento per porte e diaframmi tagliafuoco

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20090415

Year of fee payment: 8

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20091107